20
Registered trials
8
Recruiting
12
Completed trials
13
Sponsors
17
Countries
Phase III:
3
Phase II:
14
Phase I/II:
1
Phase IV:
2
Indications tested
Melanoma recurrent
2
BRAF V600E mutation positive
2
Malignant melanoma stage IV
2
Colorectal cancer
2
Colorectal adenocarcinoma
2
Malignant melanoma stage III
2
Metastatic malignant melanoma
2
Central nervous system melanoma
2
Malignant melanoma
2
Colorectal cancer metastatic
1
Non-small cell lung cancer stage IV
1
Non-small cell lung cancer
1
Sponsors using this IMP
Pfizer Inc.
6
Unicancer
2
Vall D Hebron Institute Of Oncology
2
Asociacion Grupo Tratamiento De Tumores Digestivos
1
European Organisation For Research And Treatment Of Cancer
1
Fondation Franc.Cancerologie Digestive
1
Fondazione GONO G.I.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
1
Grupo Espanol Multidisciplinar De Melanoma
1
Intergroupe Francophone De Cancerologie Thoracique
1
K-Group Beta Inc.
1
Region Hovedstaden
1
All trials
20 totalShowing 1–20 of 20 trials